|
COCP | Cocrystal Pharma, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.79 |
| Leverage | 26.58% |
| Market Cap | $ 9.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -9.7m |
| Margin | -9857.98% |
Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.